Biolife Solutions Inc financial data

Symbol
BLFS on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
3303 Monte Villa Parkway, Suite 310, Bothell, Washington
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CRYOMEDICAL SCIENCES INC (to 11/14/2002)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 283 % -7.67%
Quick Ratio 98.2 % +13.2%
Debt-to-equity 20.8 % -8.92%
Return On Assets -18.4 % 0%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.1M shares +6.09%
Common Stock, Shares, Outstanding 46.1M shares +6.13%
Entity Public Float 774M USD +63.7%
Common Stock, Value, Issued 46K USD +6.98%
Weighted Average Number of Shares Outstanding, Basic 46M shares +5.9%
Weighted Average Number of Shares Outstanding, Diluted 46M shares +5.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.8M USD +7.94%
Selling and Marketing Expense 22.9M USD +5.97%
General and Administrative Expense 51.2M USD -3.21%
Costs and Expenses 196M USD -17.4%
Operating Income (Loss) -59.5M USD +30.2%
Nonoperating Income (Expense) -4.84M USD -182%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -64.4M USD +18.9%
Income Tax Expense (Benefit) 206K USD -100%
Net Income (Loss) Attributable to Parent -73.5M USD +11.9%
Earnings Per Share, Basic -1.64 USD/shares +15.5%
Earnings Per Share, Diluted -1.64 USD/shares -95.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22M USD +2.87%
Cash, Cash Equivalents, and Short-term Investments 36.9M USD -23.3%
Accounts Receivable, after Allowance for Credit Loss, Current 18.1M USD -32.7%
Inventory, Net 32.5M USD -17.1%
Assets, Current 88.2M USD -26.7%
Property, Plant and Equipment, Net 17.3M USD -32.5%
Operating Lease, Right-of-Use Asset 10.4M USD -30.4%
Intangible Assets, Net (Excluding Goodwill) 19.3M USD -33.8%
Goodwill 225M USD 0%
Assets 375M USD -13.4%
Accounts Payable, Current 4.21M USD -60.6%
Accrued Liabilities, Current 2.8M USD -23.8%
Contract with Customer, Liability, Current 640K USD +66.2%
Liabilities, Current 30.8M USD -22.1%
Deferred Income Tax Liabilities, Net 193K USD -26.6%
Operating Lease, Liability, Noncurrent 11.1M USD -23%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 53.5M USD -33.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -555K USD -11.2%
Retained Earnings (Accumulated Deficit) -346M USD -27.7%
Stockholders' Equity Attributable to Parent 321M USD -8.71%
Liabilities and Equity 375M USD -13.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.48M USD -65%
Net Cash Provided by (Used in) Financing Activities -952K USD -69.4%
Net Cash Provided by (Used in) Investing Activities -221K USD -108%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 46.1M shares +6.13%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22M USD +2.87%
Interest Paid, Excluding Capitalized Interest, Operating Activities 445K USD -10.5%
Deferred Tax Assets, Valuation Allowance 54.7M USD +36.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 56M USD +26.1%
Operating Lease, Liability 13.6M USD -21.5%
Depreciation 3.2M USD -9.68%
Payments to Acquire Property, Plant, and Equipment 3.3M USD +126%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -73.5M USD +11.5%
Lessee, Operating Lease, Liability, to be Paid 15.4M USD -22.5%
Property, Plant and Equipment, Gross 26.9M USD -25.5%
Operating Lease, Liability, Current 2.5M USD -14.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.24M USD -24.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.79M USD -18.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 5K USD -61.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.83M USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.94M USD -23.6%
Deferred Tax Assets, Operating Loss Carryforwards 35.5M USD +22%
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 954K USD +56.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.96M USD -14.3%
Additional Paid in Capital 653M USD
Amortization of Intangible Assets 4.14M USD -39.4%
Depreciation, Depletion and Amortization 1.36M USD -20.7%
Share-based Payment Arrangement, Expense 30.2M USD +11.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%